
Supreme Court’s Decision in Kennedy v. Braidwood Management, Inc.
Explore the impact of the Supreme Court’s decision in Kennedy v. Braidwood on the ACA preventive services mandate and its implications for MedTech policy.
Explore the impact of the Supreme Court’s decision in Kennedy v. Braidwood on the ACA preventive services mandate and its implications for MedTech policy.
Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through June 17, 2025.
Member-only summary of IEEPA “fentanyl” and reciprocal tariffs under EO 14257, plus status of related legal challenges across federal courts through June 17, 2025.
Explore the latest IEEPA tariff developments and legal challenges, including executive orders on fentanyl tariffs and reciprocal duties affecting global MedTech trade.
Scott Whitaker’s Senate testimony, drug pricing EO, and updates on key RFIs drive this week’s momentum for MedTech advocacy.
The U.S. Supreme Court is reviewing Braidwood Management v. Becerra, a high-stakes case challenging the authority of the U.S. Preventive Services Task Force (USPSTF) under the Affordable Care Act. At…
Domestic manufacturing EO, federal reforms, and critical RFIs signal changes for MedTech—member input still welcome.
No FDA overhaul, new federal procurement EOs, and a major court case could shift preventive care coverage requirements.
FDA reorg, port fees, and policy shifts top this week’s update—plus, help shape future AdvaMed rapid response priorities.
Although the individual claims may differ, a review of recent products liability claims levied against industries targeted by the plaintiffs trial bar reveals common threads. For example, the drivers of…